vs
Side-by-side financial comparison of ACV Auctions Inc. (ACVA) and AVANOS MEDICAL, INC. (AVNS). Click either name above to swap in a different company.
ACV Auctions Inc. is the larger business by last-quarter revenue ($183.6M vs $180.9M, roughly 1.0× AVANOS MEDICAL, INC.). On growth, ACV Auctions Inc. posted the faster year-over-year revenue change (15.1% vs 0.7%). AVANOS MEDICAL, INC. produced more free cash flow last quarter ($21.3M vs $-14.7M). Over the past eight quarters, ACV Auctions Inc.'s revenue compounded faster (12.3% CAGR vs 4.4%).
ACV Auctions Inc.ACVAEarnings & Financial Report
ACV Auctions Inc. operates a leading digital wholesale vehicle auction platform serving automotive dealers across the U.S. and Canada. It offers end-to-end services including transparent vehicle inspections, secure payment processing, and logistics support, enabling efficient trading of used vehicles between registered wholesale buyers and sellers.
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
ACVA vs AVNS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $183.6M | $180.9M |
| Net Profit | — | $-1.3M |
| Gross Margin | — | 47.5% |
| Operating Margin | -9.7% | 1.4% |
| Net Margin | — | -0.7% |
| Revenue YoY | 15.1% | 0.7% |
| Net Profit YoY | — | 99.7% |
| EPS (diluted) | $-0.12 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $183.6M | $180.9M | ||
| Q3 25 | $199.6M | $177.8M | ||
| Q2 25 | $193.7M | $175.0M | ||
| Q1 25 | $182.7M | $167.5M | ||
| Q4 24 | $159.5M | $179.6M | ||
| Q3 24 | $171.3M | $170.4M | ||
| Q2 24 | $160.6M | $171.7M | ||
| Q1 24 | $145.7M | $166.1M |
| Q4 25 | — | $-1.3M | ||
| Q3 25 | $-24.5M | $-1.4M | ||
| Q2 25 | $-7.3M | $-76.8M | ||
| Q1 25 | $-14.8M | $6.6M | ||
| Q4 24 | — | $-397.3M | ||
| Q3 24 | $-16.0M | $4.3M | ||
| Q2 24 | $-17.1M | $1.8M | ||
| Q1 24 | $-20.5M | $-900.0K |
| Q4 25 | — | 47.5% | ||
| Q3 25 | — | 48.4% | ||
| Q2 25 | — | 52.6% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 54.6% | ||
| Q3 24 | — | 54.5% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 57.1% |
| Q4 25 | -9.7% | 1.4% | ||
| Q3 25 | -11.9% | 0.1% | ||
| Q2 25 | -3.7% | -42.6% | ||
| Q1 25 | -7.9% | 6.1% | ||
| Q4 24 | -16.2% | -233.0% | ||
| Q3 24 | -10.0% | 7.0% | ||
| Q2 24 | -11.6% | 3.7% | ||
| Q1 24 | -15.5% | 2.4% |
| Q4 25 | — | -0.7% | ||
| Q3 25 | -12.3% | -0.8% | ||
| Q2 25 | -3.8% | -43.9% | ||
| Q1 25 | -8.1% | 3.9% | ||
| Q4 24 | — | -221.2% | ||
| Q3 24 | -9.4% | 2.5% | ||
| Q2 24 | -10.6% | 1.0% | ||
| Q1 24 | -14.1% | -0.5% |
| Q4 25 | $-0.12 | $-0.02 | ||
| Q3 25 | $-0.14 | $-0.03 | ||
| Q2 25 | $-0.04 | $-1.66 | ||
| Q1 25 | $-0.09 | $0.14 | ||
| Q4 24 | $-0.15 | $-8.64 | ||
| Q3 24 | $-0.10 | $0.09 | ||
| Q2 24 | $-0.10 | $0.04 | ||
| Q1 24 | $-0.13 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $271.5M | $89.8M |
| Total DebtLower is stronger | — | $90.3M |
| Stockholders' EquityBook value | $429.7M | $778.2M |
| Total Assets | $1.1B | $1.1B |
| Debt / EquityLower = less leverage | — | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $271.5M | $89.8M | ||
| Q3 25 | $265.3M | $70.5M | ||
| Q2 25 | $258.4M | $90.3M | ||
| Q1 25 | $291.9M | $97.0M | ||
| Q4 24 | $224.1M | $107.7M | ||
| Q3 24 | $252.5M | $89.0M | ||
| Q2 24 | $215.0M | $92.2M | ||
| Q1 24 | $209.8M | $75.8M |
| Q4 25 | — | $90.3M | ||
| Q3 25 | — | $93.4M | ||
| Q2 25 | — | $95.7M | ||
| Q1 25 | — | $98.0M | ||
| Q4 24 | — | $125.3M | ||
| Q3 24 | — | $152.6M | ||
| Q2 24 | — | $164.9M | ||
| Q1 24 | — | $167.2M |
| Q4 25 | $429.7M | $778.2M | ||
| Q3 25 | $434.4M | $778.0M | ||
| Q2 25 | $448.8M | $776.3M | ||
| Q1 25 | $439.6M | $839.4M | ||
| Q4 24 | $440.0M | $828.5M | ||
| Q3 24 | $456.2M | $1.2B | ||
| Q2 24 | $457.6M | $1.2B | ||
| Q1 24 | $458.3M | $1.2B |
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.2B | $1.1B | ||
| Q2 25 | $1.1B | $1.0B | ||
| Q1 25 | $1.2B | $1.1B | ||
| Q4 24 | $984.1M | $1.2B | ||
| Q3 24 | $1.0B | $1.7B | ||
| Q2 24 | $1.0B | $1.7B | ||
| Q1 24 | $1.0B | $1.7B |
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.13× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-12.4M | $28.2M |
| Free Cash FlowOCF − Capex | $-14.7M | $21.3M |
| FCF MarginFCF / Revenue | -8.0% | 11.8% |
| Capex IntensityCapex / Revenue | 1.2% | 3.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $69.1M | $43.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-12.4M | $28.2M | ||
| Q3 25 | $10.3M | $14.0M | ||
| Q2 25 | $13.7M | $6.8M | ||
| Q1 25 | $66.6M | $25.7M | ||
| Q4 24 | $-3.2M | $57.9M | ||
| Q3 24 | $21.1M | $23.0M | ||
| Q2 24 | $4.5M | $27.8M | ||
| Q1 24 | $43.0M | $-8.0M |
| Q4 25 | $-14.7M | $21.3M | ||
| Q3 25 | $7.7M | $7.0M | ||
| Q2 25 | $10.9M | $-4.2M | ||
| Q1 25 | $65.3M | $19.0M | ||
| Q4 24 | $-3.9M | $53.1M | ||
| Q3 24 | $20.2M | $20.0M | ||
| Q2 24 | $2.7M | $21.9M | ||
| Q1 24 | $41.9M | $-12.1M |
| Q4 25 | -8.0% | 11.8% | ||
| Q3 25 | 3.8% | 3.9% | ||
| Q2 25 | 5.6% | -2.4% | ||
| Q1 25 | 35.7% | 11.3% | ||
| Q4 24 | -2.5% | 29.6% | ||
| Q3 24 | 11.8% | 11.7% | ||
| Q2 24 | 1.7% | 12.8% | ||
| Q1 24 | 28.8% | -7.3% |
| Q4 25 | 1.2% | 3.8% | ||
| Q3 25 | 1.3% | 3.9% | ||
| Q2 25 | 1.5% | 6.3% | ||
| Q1 25 | 0.7% | 4.0% | ||
| Q4 24 | 0.4% | 2.7% | ||
| Q3 24 | 0.6% | 1.8% | ||
| Q2 24 | 1.1% | 3.4% | ||
| Q1 24 | 0.7% | 2.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.89× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.35× | ||
| Q2 24 | — | 15.44× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACVA
| Auction Marketplace Revenue | $77.6M | 42% |
| Other Marketplace Revenue | $72.4M | 39% |
| Customer Assurance | $24.1M | 13% |
| Data Services Revenue | $9.4M | 5% |
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
